Skip to main content
Erschienen in: Current Psychiatry Reports 6/2010

01.12.2010

Overview of the Genetics of Major Depressive Disorder

verfasst von: Falk W. Lohoff

Erschienen in: Current Psychiatry Reports | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Major depressive disorder (MDD) is a common psychiatric illness with high levels of morbidity and mortality. Despite intensive research during the past several decades, the neurobiological basis and pathophysiology of depressive disorders remain unknown. Genetic factors play important roles in the development of MDD, as indicated by family, twin, and adoption studies, and may reveal important information about disease mechanisms. This article describes recent developments in the field of psychiatric genetics, with a focus on MDD. Early twin studies, linkage studies, and association studies are discussed. Recent findings from genome-wide association studies are reviewed and future directions discussed. Despite all efforts, thus far, no single genetic variation has been identified to increase the risk of depression substantially. Genetic variants are expected to have only small effects on overall disease risk, and multiple genetic factors in conjunction with environmental factors are likely necessary for the development of MDD. Future large-scale studies are needed to dissect this complex phenotype and to identify pathways involved in the etiology of MDD.
Literatur
1.
Zurück zum Zitat Tsuang MT, Taylor L, Faraone SV: An overview of the genetics of psychotic mood disorders. J Psychiatr Res 2004, 38:3–15.CrossRefPubMed Tsuang MT, Taylor L, Faraone SV: An overview of the genetics of psychotic mood disorders. J Psychiatr Res 2004, 38:3–15.CrossRefPubMed
2.
Zurück zum Zitat Kessler RC, Chiu WT, Demler O, et al.: Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62:617–627.CrossRefPubMed Kessler RC, Chiu WT, Demler O, et al.: Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62:617–627.CrossRefPubMed
3.
Zurück zum Zitat Lohoff FW, Berrettini WH: Genetics of mood disorders. In Neurobiology of Mental Illness. Edited by Charney DS. New York: Oxford University Press; 2008:1504. Lohoff FW, Berrettini WH: Genetics of mood disorders. In Neurobiology of Mental Illness. Edited by Charney DS. New York: Oxford University Press; 2008:1504.
4.
Zurück zum Zitat Sullivan PF, Neale MC, Kendler KS: Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000, 157:1552–1562.CrossRefPubMed Sullivan PF, Neale MC, Kendler KS: Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000, 157:1552–1562.CrossRefPubMed
5.
Zurück zum Zitat Weissman MM, Wickramaratne P, Adams PB, et al.: The relationship between panic disorder and major depression. A new family study. Arch Gen Psychiatry 1993, 50:767–780.PubMed Weissman MM, Wickramaratne P, Adams PB, et al.: The relationship between panic disorder and major depression. A new family study. Arch Gen Psychiatry 1993, 50:767–780.PubMed
6.
7.
Zurück zum Zitat Holmans P, Zubenko GS, Crowe RR, et al.: Genomewide significant linkage to recurrent, early-onset major depressive disorder on chromosome 15q. Am J Hum Genet 2004, 74:1154–1167.CrossRefPubMed Holmans P, Zubenko GS, Crowe RR, et al.: Genomewide significant linkage to recurrent, early-onset major depressive disorder on chromosome 15q. Am J Hum Genet 2004, 74:1154–1167.CrossRefPubMed
8.
Zurück zum Zitat Holmans P, Weissman MM, Zubenko GS, et al.: Genetics of recurrent early-onset major depression (GenRED): final genome scan report. Am J Psychiatry 2007, 164:248–258.CrossRefPubMed Holmans P, Weissman MM, Zubenko GS, et al.: Genetics of recurrent early-onset major depression (GenRED): final genome scan report. Am J Psychiatry 2007, 164:248–258.CrossRefPubMed
9.
Zurück zum Zitat Levinson DF, Evgrafov OV, Knowles JA, et al.: Genetics of recurrent early-onset major depression (GenRED): significant linkage on chromosome 15q25-q26 after fine mapping with single nucleotide polymorphism markers. Am J Psychiatry 2007, 164:259–264.CrossRefPubMed Levinson DF, Evgrafov OV, Knowles JA, et al.: Genetics of recurrent early-onset major depression (GenRED): significant linkage on chromosome 15q25-q26 after fine mapping with single nucleotide polymorphism markers. Am J Psychiatry 2007, 164:259–264.CrossRefPubMed
10.
Zurück zum Zitat Abkevich V, Camp NJ, Hensel CH, et al.: Predisposition locus for major depression at chromosome 12q22-12q23.2. Am J Hum Genet 2003, 73:1271–1281.CrossRefPubMed Abkevich V, Camp NJ, Hensel CH, et al.: Predisposition locus for major depression at chromosome 12q22-12q23.2. Am J Hum Genet 2003, 73:1271–1281.CrossRefPubMed
11.
Zurück zum Zitat Camp NJ, Lowry MR, Richards RL, et al.: Genome-wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent, early-onset major depression and anxiety disorders. Am J Med Genet B Neuropsychiatr Genet 2005, 135:85–93. Camp NJ, Lowry MR, Richards RL, et al.: Genome-wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent, early-onset major depression and anxiety disorders. Am J Med Genet B Neuropsychiatr Genet 2005, 135:85–93.
12.
Zurück zum Zitat McGuffin P, Knight J, Breen G, et al.: Whole genome linkage scan of recurrent depressive disorder from the Depression Network study. Hum Mol Genet 2005, 14:3337–3345.CrossRefPubMed McGuffin P, Knight J, Breen G, et al.: Whole genome linkage scan of recurrent depressive disorder from the Depression Network study. Hum Mol Genet 2005, 14:3337–3345.CrossRefPubMed
13.
Zurück zum Zitat Hamilton SP, Fyer AJ, Durner M, et al.: Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. Proc Natl Acad Sci U S A 2003, 100:2550–2555.CrossRefPubMed Hamilton SP, Fyer AJ, Durner M, et al.: Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. Proc Natl Acad Sci U S A 2003, 100:2550–2555.CrossRefPubMed
14.
Zurück zum Zitat Middeldorp CM, Sullivan PF, Wray NR, et al.: Suggestive linkage on chromosome 2, 8, and 17 for lifetime major depression. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:352–358.CrossRefPubMed Middeldorp CM, Sullivan PF, Wray NR, et al.: Suggestive linkage on chromosome 2, 8, and 17 for lifetime major depression. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:352–358.CrossRefPubMed
15.
Zurück zum Zitat Cloninger CR, Van Eerdewegh P, Goate A, et al.: Anxiety proneness linked to epistatic loci in genome scan of human personality traits. Am J Med Genet 1998, 81:313–317.CrossRefPubMed Cloninger CR, Van Eerdewegh P, Goate A, et al.: Anxiety proneness linked to epistatic loci in genome scan of human personality traits. Am J Med Genet 1998, 81:313–317.CrossRefPubMed
16.
Zurück zum Zitat Fullerton J, Cubin M, Tiwari H, et al.: Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative-trait loci that influence variation in the human personality trait neuroticism. Am J Hum Genet 2003, 72:879–890.CrossRefPubMed Fullerton J, Cubin M, Tiwari H, et al.: Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative-trait loci that influence variation in the human personality trait neuroticism. Am J Hum Genet 2003, 72:879–890.CrossRefPubMed
17.
Zurück zum Zitat Caspi A, Hariri AR, Holmes A, et al.: Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 2010, 167:509–527.CrossRefPubMed Caspi A, Hariri AR, Holmes A, et al.: Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 2010, 167:509–527.CrossRefPubMed
18.
Zurück zum Zitat Goldman N, Glei DA, Lin YH, et al.: The serotonin transporter polymorphism (5-HTTLPR): allelic variation and links with depressive symptoms. Depress Anxiety 2010, 27:260–269.CrossRefPubMed Goldman N, Glei DA, Lin YH, et al.: The serotonin transporter polymorphism (5-HTTLPR): allelic variation and links with depressive symptoms. Depress Anxiety 2010, 27:260–269.CrossRefPubMed
19.
Zurück zum Zitat Uher R, McGuffin P: The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Mol Psychiatry 2010, 15:18–22.CrossRefPubMed Uher R, McGuffin P: The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Mol Psychiatry 2010, 15:18–22.CrossRefPubMed
20.
Zurück zum Zitat Lesch KP, Bengel D, Heils A, et al.: Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527–1531.CrossRefPubMed Lesch KP, Bengel D, Heils A, et al.: Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527–1531.CrossRefPubMed
21.
Zurück zum Zitat Caspi A, Sugden K, Moffitt TE, et al.: Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386–389.CrossRefPubMed Caspi A, Sugden K, Moffitt TE, et al.: Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386–389.CrossRefPubMed
22.
Zurück zum Zitat • Risch N, Herrell R, Lehner T, et al.: Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 2009, 301:2462–2471. This large meta-analysis of the serotonin transporter gene 5-HTTLPR polymorphism found no evidence for an association with stressful life events or increased risk for depression.CrossRefPubMed • Risch N, Herrell R, Lehner T, et al.: Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 2009, 301:2462–2471. This large meta-analysis of the serotonin transporter gene 5-HTTLPR polymorphism found no evidence for an association with stressful life events or increased risk for depression.CrossRefPubMed
23.
Zurück zum Zitat Anguelova M, Benkelfat C, Turecki G: A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders. Mol Psychiatry 2003, 8:574–591.CrossRefPubMed Anguelova M, Benkelfat C, Turecki G: A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders. Mol Psychiatry 2003, 8:574–591.CrossRefPubMed
24.
Zurück zum Zitat Lohoff FW, Ferraro TN: Pharmacogenetic considerations in the treatment of psychiatric disorders. Expert Opin Pharmacother 2010, 11:423–439.CrossRefPubMed Lohoff FW, Ferraro TN: Pharmacogenetic considerations in the treatment of psychiatric disorders. Expert Opin Pharmacother 2010, 11:423–439.CrossRefPubMed
25.
Zurück zum Zitat Serretti A, Kato M, De Ronchi D, et al.: Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry 2007, 12:247–257.PubMed Serretti A, Kato M, De Ronchi D, et al.: Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry 2007, 12:247–257.PubMed
26.
Zurück zum Zitat McMahon FJ, Buervenich S, Charney D, et al.: Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet 2006, 78:804–814.CrossRefPubMed McMahon FJ, Buervenich S, Charney D, et al.: Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet 2006, 78:804–814.CrossRefPubMed
27.
Zurück zum Zitat Uher R, Farmer A, Maier W, et al.: Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol Med 2008, 38:289–300.CrossRefPubMed Uher R, Farmer A, Maier W, et al.: Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol Med 2008, 38:289–300.CrossRefPubMed
28.
Zurück zum Zitat Uher R, Huezo-Diaz P, Perroud N, et al.: Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenomics J 2009, 9:225–233.CrossRefPubMed Uher R, Huezo-Diaz P, Perroud N, et al.: Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenomics J 2009, 9:225–233.CrossRefPubMed
29.
Zurück zum Zitat Kendler KS, Kessler RC, Walters EE, et al.: Stressful life events, genetic liability, and onset of an episode of major depression in women. Am J Psychiatry 1995, 152:833–842.PubMed Kendler KS, Kessler RC, Walters EE, et al.: Stressful life events, genetic liability, and onset of an episode of major depression in women. Am J Psychiatry 1995, 152:833–842.PubMed
30.
Zurück zum Zitat Jokela M, Keltikangas-Jarvinen L, Kivimaki M, et al.: Serotonin receptor 2A gene and the influence of childhood maternal nurturance on adulthood depressive symptoms. Arch Gen Psychiatry 2007, 64:356–360.CrossRefPubMed Jokela M, Keltikangas-Jarvinen L, Kivimaki M, et al.: Serotonin receptor 2A gene and the influence of childhood maternal nurturance on adulthood depressive symptoms. Arch Gen Psychiatry 2007, 64:356–360.CrossRefPubMed
31.
Zurück zum Zitat Castren E, Rantamaki T: The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev Neurobiol 2010, 70:289–297.PubMed Castren E, Rantamaki T: The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev Neurobiol 2010, 70:289–297.PubMed
32.
Zurück zum Zitat Post RM: Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J Psychiatr Res 2007, 41:979–990.CrossRefPubMed Post RM: Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J Psychiatr Res 2007, 41:979–990.CrossRefPubMed
33.
Zurück zum Zitat Duman RS: Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 2004, 5:11–25.CrossRefPubMed Duman RS: Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 2004, 5:11–25.CrossRefPubMed
34.
Zurück zum Zitat Roceri M, Cirulli F, Pessina C, et al.: Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions. Biol Psychiatry 2004, 55:708–714.CrossRefPubMed Roceri M, Cirulli F, Pessina C, et al.: Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions. Biol Psychiatry 2004, 55:708–714.CrossRefPubMed
35.
Zurück zum Zitat Nibuya M, Morinobu S, Duman RS: Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995, 15:7539–7547.PubMed Nibuya M, Morinobu S, Duman RS: Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995, 15:7539–7547.PubMed
36.
Zurück zum Zitat Schumacher J, Jamra RA, Becker T, et al.: Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 2005, 58:307–314.CrossRefPubMed Schumacher J, Jamra RA, Becker T, et al.: Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 2005, 58:307–314.CrossRefPubMed
37.
Zurück zum Zitat Surtees PG, Wainwright NW, Willis-Owen SA, et al.: No association between the BDNF Val66Met polymorphism and mood status in a non-clinical community sample of 7389 older adults. J Psychiatr Res 2007, 41:404–409.CrossRefPubMed Surtees PG, Wainwright NW, Willis-Owen SA, et al.: No association between the BDNF Val66Met polymorphism and mood status in a non-clinical community sample of 7389 older adults. J Psychiatr Res 2007, 41:404–409.CrossRefPubMed
38.
Zurück zum Zitat Hashimoto K: Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin Neurosci 2010, 64:341–357.CrossRefPubMed Hashimoto K: Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin Neurosci 2010, 64:341–357.CrossRefPubMed
39.
Zurück zum Zitat Walther DJ, Bader M: A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 2003, 66:1673–1680.CrossRefPubMed Walther DJ, Bader M: A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 2003, 66:1673–1680.CrossRefPubMed
40.
Zurück zum Zitat Zill P, Baghai TC, Zwanzger P, et al.: SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol Psychiatry 2004, 9:1030–1036.CrossRefPubMed Zill P, Baghai TC, Zwanzger P, et al.: SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol Psychiatry 2004, 9:1030–1036.CrossRefPubMed
41.
Zurück zum Zitat Zhang X, Gainetdinov RR, Beaulieu JM, et al.: Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 2005, 45:11–16.CrossRefPubMed Zhang X, Gainetdinov RR, Beaulieu JM, et al.: Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 2005, 45:11–16.CrossRefPubMed
42.
Zurück zum Zitat Van Den Bogaert A, Sleegers K, De Zutter S, et al.: Association of brain-specific tryptophan hydroxylase, TPH2, with unipolar and bipolar disorder in a Northern Swedish, isolated population. Arch Gen Psychiatry 2006, 63:1103–1110.CrossRef Van Den Bogaert A, Sleegers K, De Zutter S, et al.: Association of brain-specific tryptophan hydroxylase, TPH2, with unipolar and bipolar disorder in a Northern Swedish, isolated population. Arch Gen Psychiatry 2006, 63:1103–1110.CrossRef
43.
Zurück zum Zitat Lopez VA, Detera-Wadleigh S, Cardona I, et al.: Nested association between genetic variation in tryptophan hydroxylase II, bipolar affective disorder, and suicide attempts. Biol Psychiatry 2007, 61:181–186.CrossRefPubMed Lopez VA, Detera-Wadleigh S, Cardona I, et al.: Nested association between genetic variation in tryptophan hydroxylase II, bipolar affective disorder, and suicide attempts. Biol Psychiatry 2007, 61:181–186.CrossRefPubMed
44.
Zurück zum Zitat De Luca V, Mueller DJ, Tharmalingam S, et al.: Analysis of the novel TPH2 gene in bipolar disorder and suicidality. Mol Psychiatry 2004, 9:896–897.CrossRefPubMed De Luca V, Mueller DJ, Tharmalingam S, et al.: Analysis of the novel TPH2 gene in bipolar disorder and suicidality. Mol Psychiatry 2004, 9:896–897.CrossRefPubMed
45.
Zurück zum Zitat Lopez-Leon S, Janssens AC, Gonzalez-Zuloeta Ladd AM, et al.: Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry 2008, 13:772–785.CrossRefPubMed Lopez-Leon S, Janssens AC, Gonzalez-Zuloeta Ladd AM, et al.: Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry 2008, 13:772–785.CrossRefPubMed
46.
Zurück zum Zitat Pearson TA, Manolio TA: How to interpret a genome-wide association study. JAMA 2008, 299:1335–1344.CrossRefPubMed Pearson TA, Manolio TA: How to interpret a genome-wide association study. JAMA 2008, 299:1335–1344.CrossRefPubMed
47.
Zurück zum Zitat Jorgenson E, Witte JS: A gene-centric approach to genome-wide association studies. Nat Rev Genet 2006, 7:885–891.CrossRefPubMed Jorgenson E, Witte JS: A gene-centric approach to genome-wide association studies. Nat Rev Genet 2006, 7:885–891.CrossRefPubMed
48.
Zurück zum Zitat Clark AG, Boerwinkle E, Hixson J, et al.: Determinants of the success of whole-genome association testing. Genome Res 2005, 15:1463–1467.CrossRefPubMed Clark AG, Boerwinkle E, Hixson J, et al.: Determinants of the success of whole-genome association testing. Genome Res 2005, 15:1463–1467.CrossRefPubMed
49.
Zurück zum Zitat Welcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661–678.CrossRef Welcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661–678.CrossRef
50.
Zurück zum Zitat Cichon S, Craddock N, Daly M, et al.: Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am J Psychiatry 2009, 166:540–556.CrossRefPubMed Cichon S, Craddock N, Daly M, et al.: Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am J Psychiatry 2009, 166:540–556.CrossRefPubMed
51.
Zurück zum Zitat • Sullivan PF, de Geus EJ, Willemsen G, et al.: Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry 2009, 14:359–375. This was the first GWAS in depression. Results did not achieve genome-wide significance but suggest a potential role for the PCLO gene.CrossRefPubMed • Sullivan PF, de Geus EJ, Willemsen G, et al.: Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry 2009, 14:359–375. This was the first GWAS in depression. Results did not achieve genome-wide significance but suggest a potential role for the PCLO gene.CrossRefPubMed
52.
Zurück zum Zitat Lewis CM, Ng MY, Butler AW, et al.: Genome-wide association study of major recurrent depression in the U.K. population. Am J Psychiatry 2010, 167:949–957.CrossRefPubMed Lewis CM, Ng MY, Butler AW, et al.: Genome-wide association study of major recurrent depression in the U.K. population. Am J Psychiatry 2010, 167:949–957.CrossRefPubMed
53.
Zurück zum Zitat Muglia P, Tozzi F, Galwey NW, et al.: Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Mol Psychiatry 2010, 15:589–601.CrossRefPubMed Muglia P, Tozzi F, Galwey NW, et al.: Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Mol Psychiatry 2010, 15:589–601.CrossRefPubMed
54.
Zurück zum Zitat Shi J, Potash JB, Knowles JA, et al.: Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry 2010 Feb 2 (Epub ahead of print). Shi J, Potash JB, Knowles JA, et al.: Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry 2010 Feb 2 (Epub ahead of print).
55.
Zurück zum Zitat Shyn SI, Shi J, Kraft JB, et al.: Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies. Mol Psychiatry 2009 Dec 29 (Epub ahead of print). Shyn SI, Shi J, Kraft JB, et al.: Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies. Mol Psychiatry 2009 Dec 29 (Epub ahead of print).
56.
Zurück zum Zitat Lohoff FW, Dahl JP, Ferraro TN, et al.: Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar I disorder. Neuropsychopharmacology 2006, 31:2739–2747.CrossRefPubMed Lohoff FW, Dahl JP, Ferraro TN, et al.: Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar I disorder. Neuropsychopharmacology 2006, 31:2739–2747.CrossRefPubMed
57.
Zurück zum Zitat Zhou X, Tang W, Greenwood TA, et al.: Transcription factor SP4 is a susceptibility gene for bipolar disorder. PLoS One 2009, 4:e5196.CrossRefPubMed Zhou X, Tang W, Greenwood TA, et al.: Transcription factor SP4 is a susceptibility gene for bipolar disorder. PLoS One 2009, 4:e5196.CrossRefPubMed
58.
Zurück zum Zitat • McMahon FJ, Akula N, Schulze TG, et al.; Bipolar Disorder Genome Study (BiGS) Consortium: Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. Nat Genet 2010, 42:128–131. This is the largest meta-analysis of mood disorders to date, including more than 13,600 individuals genotyped on high-density SNP arrays. The study identified SNPs at 3p21.1 associated with major mood disorders.CrossRefPubMed • McMahon FJ, Akula N, Schulze TG, et al.; Bipolar Disorder Genome Study (BiGS) Consortium: Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. Nat Genet 2010, 42:128–131. This is the largest meta-analysis of mood disorders to date, including more than 13,600 individuals genotyped on high-density SNP arrays. The study identified SNPs at 3p21.1 associated with major mood disorders.CrossRefPubMed
59.
Zurück zum Zitat Willett WC: Balancing life-style and genomics research for disease prevention. Science 2002, 296:695–698.CrossRefPubMed Willett WC: Balancing life-style and genomics research for disease prevention. Science 2002, 296:695–698.CrossRefPubMed
Metadaten
Titel
Overview of the Genetics of Major Depressive Disorder
verfasst von
Falk W. Lohoff
Publikationsdatum
01.12.2010
Verlag
Current Science Inc.
Erschienen in
Current Psychiatry Reports / Ausgabe 6/2010
Print ISSN: 1523-3812
Elektronische ISSN: 1535-1645
DOI
https://doi.org/10.1007/s11920-010-0150-6

Weitere Artikel der Ausgabe 6/2010

Current Psychiatry Reports 6/2010 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.